Internal Medicine, Interventional Cardiology · Moline, IL
NPI
1104805092
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
7
Medicare group memberships
Hospitals
5
Hospital affiliations
1100 36th Avenue
Moline, IL, 61265
Phone (309) 743-6700
Groups this clinician bills Medicare through
Medicare paid, 2024
$589K
9,912 services
Medicare patients, 2024
1,420
Average age 76
Drug cost, 2024
$973K
8,532 prescriptions
Company payments, 2025
$149
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Faraz Manazir was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 5,700 times for 58 patients. In total Faraz Manazir billed 9,912 services in 87 codes, and Medicare paid $589K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-10.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 5,700 | 58 | $0.10 | $593 |
| 93000 Electrocardiogram | Office | 469 | 430 | $9.72 | $4,559 |
| 99214 Office E&M - Established | Office | 452 | 395 | $84.46 | $38K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 412 | 103 | $5.33 | $2,195 |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 412 | 206 | $404.24 | $167K |
| 93010 Electrocardiogram | Facility | 365 | 307 | $5.73 | $2,090 |
| 93306 Echocardiography (TTE/TEE) | Office | 296 | 290 | $118.12 | $35K |
| 93018 Electrocardiogram | Office | 180 | 180 | $10.48 | $1,886 |
| 78434 Myocardial Perfusion Scan | Office | 169 | 169 | $97.06 | $16K |
| 78431 Myocardial Perfusion Scan | Office | 165 | 165 | $1,193.20 | $197K |
| 99213 Office E&M - Established | Office | 126 | 118 | $55.66 | $7,013 |
| 93016 Electrocardiogram | Office | 83 | 83 | $14.85 | $1,232 |
| 93017 Electrocardiogram | Office | 82 | 82 | $24.96 | $2,046 |
| G0250 Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Office | 81 | 11 | $6.37 | $516 |
| 99204 Office E&M - New | Office | 74 | 74 | $110.73 | $8,194 |
By year: 2022 $433K for 10,668 services; 2023 $504K for 10,488 services; 2024 $589K for 9,912 services.
Medicare prescription drug claims, 2024
In 2024, the drug Faraz Manazir prescribed most often to Medicare patients was Metoprolol Succinate, with 977 prescriptions and refills. In total Faraz Manazir wrote 8,532 Medicare prescriptions that cost $973K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 977 | 2,631 | 331 | $13K |
| Clopidogrel Clopidogrel Bisulfate | 705 | 1,880 | 219 | $7,221 |
| Amlodipine Besylate Generic | 563 | 1,440 | 184 | $3,478 |
| Lisinopril Generic | 519 | 1,398 | 181 | $3,541 |
| Eliquis Apixaban | 450 | 881 | 130 | $507K |
| Atorvastatin Calcium Generic | 438 | 1,123 | 142 | $3,781 |
| Rosuvastatin Calcium Generic | 434 | 1,111 | 144 | $4,073 |
| Metoprolol Tartrate Generic | 411 | 1,071 | 134 | $2,610 |
| Losartan Potassium Generic | 371 | 866 | 102 | $2,936 |
| Furosemide Generic | 332 | 803 | 116 | $1,830 |
| Potassium Chloride Generic | 312 | 732 | 106 | $6,141 |
| Carvedilol Generic | 245 | 651 | 84 | $1,807 |
| Nitroglycerin Patch Nitroglycerin | 239 | 531 | 85 | $15K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 180 | 516 | 64 | $2,671 |
| Spironolactone Generic | 177 | 409 | 63 | $940 |
Brand drugs: 898 claims; generic drugs: 7,634 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Faraz Manazir $149 ($149 in general payments such as food, travel and fees) from 3 companies. The largest payer was CVRx, Inc. with $88.72.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.